{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:05:13Z","timestamp":1791929113968,"version":"4.3.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Background<\/jats:title>\n Several systematic reviews and meta-analyses have investigated the effect of levothyroxine (LT4) therapy in pregnant women with subclinical hypothyroidism (SCH). However, all these studies have clinical or methodological problems (such as adopting the old 2011 American Thyroid Association [ATA] diagnostic criteria, directly combining randomized controlled trials [RCTs] and cohort studies for meta-analysis, and so on), and cannot provide accurate and satisfactory results. Thus, we performed this updated systematic review, meta-analysis and trial sequential analysis (TSA) to assess the effect of LT4 therapy in pregnant women with SCH, with the goal of providing more accurate and reliable evidence for clinical practice.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We searched nine databases from inception to February 2022. The search strategy targeted the RCTs and cohort studies on pregnancy, neonatal and childhood outcomes following LT4 treatment in pregnant women with SCH based on the new 2017 ATA diagnostic criteria. We performed meta-analyses of RCTs and cohort studies separately, and further performed meta-analyses by excluding studies with high risk of bias. TSA was performed to test whether the current evidence was sufficient, and the quality of evidence was evaluated using the GRADE method.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 9 RCTs and 13 cohort studies comprising 11273 pregnant women with SCH were included. There were no statistically significant differences between LT4 group and control group in all primary and secondary outcomes, such as preterm delivery (RR=0.46, 95%CI: 0.19-1.09,\n P<\/jats:italic>\n =0.08, I\n 2 =<\/jats:sup>\n 65%), miscarriage (RR=0.36, 95%CI: 0.13-1.03,\n P<\/jats:italic>\n =0.06, I\n 2 =<\/jats:sup>\n 38%), gestational hypertension (RR=0.91, 95%CI: 0.58-1.43,\n P<\/jats:italic>\n =0.69, I\n 2 =<\/jats:sup>\n 0%), preeclampsia (RR=1.10, 95%CI: 0.61-1.97,\n P<\/jats:italic>\n =0.76, I\n 2 =<\/jats:sup>\n 0%), gestational diabetes (RR=0.80, 95%CI: 0.51-1.25,\n P<\/jats:italic>\n =0.32, I\n 2 =<\/jats:sup>\n 34%), and so on. TSA showed that the results for all outcomes were insufficient and inconclusive. According to GRADE, the evidences for four outcomes (miscarriage, gestational hypertension, gestational diabetes, and small for gestational age) were rated as moderate quality, while the evidences for the other outcomes were rated as low or very low quality.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Unlike previous systematic reviews and meta-analyses, our study found no evidence of benefit of LT4 therapy on pregnancy, neonatal and childhood outcomes in pregnant women with SCH.<\/jats:p>\n <\/jats:sec>\n \n Systematic Review Registration<\/jats:title>\n \n PROSPERO,\n https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022321937<\/jats:uri>\n , identifier CRD42022321937.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2022.964084","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T03:27:17Z","timestamp":1659670037000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["The impact of levothyroxine therapy on the pregnancy, neonatal and childhood outcomes of subclinical hypothyroidism during pregnancy: An updated systematic review, meta-analysis and trial sequential analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xue-Feng","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0418","article-title":"Subclinical hypothyroidism in pregnancy: A systematic review and meta-analysis","volume":"26","author":"Maraka","year":"2016","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis","volume":"99","author":"Garmendia Madariaga","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2018.3.21621","article-title":"Prevalence of subclinical hypothyroidism in pregnancy in Saudi Arabia","volume":"39","author":"Al Shanqeeti","year":"2018","journal-title":"Saudi Med J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00196","article-title":"Practice variation in the care of subclinical hypothyroidism during pregnancy: A national survey of physicians in the united states","volume":"3","author":"Toloza","year":"2019","journal-title":"J Endocr Soc"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1000-6699","article-title":"Guidelines for the diagnosis and treatment of thyroid diseases during pregnancy and postpartum (2nd edition)","volume":"35","year":"2019","journal-title":"Chin J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000003893","article-title":"Thyroid disease in pregnancy: ACOG practice bulletin, number 223","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.797423","article-title":"Pregnancy and neonatal outcomes with levothyroxine treatment in women with subclinical hypothyroidism based on new diagnostic criteria: A systematic review and meta-analysis","volume":"12","author":"Ding","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","unstructured":"HigginsJ\n ThomasJ\n CumpstonM\n LiTJ\n PageM\n WelchV\n Cochrane handbook for systematic reviews of interventions version 6.3, 2022"},{"key":"B10","unstructured":"ThorlundK\n Engstr\u00f8mJ\n WetterslevJ\n BrokJ\n ImbergerG\n GluudC\n User manual for trial sequential analysis (TSA)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. rating the quality of evidence\u2013study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr15049019","article-title":"Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy","volume":"15","author":"Ju","year":"2016","journal-title":"Genet Mol Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.12.004","article-title":"Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01850","article-title":"Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies","volume":"103","author":"Nazarpour","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-0548","article-title":"Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease","volume":"176","author":"Nazarpour","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13341","article-title":"Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss","volume":"85","author":"Yoshihara","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0374","article-title":"Subclinical hypothyroidism with negative for thyroid peroxidase antibodies in pregnancy: Intellectual development of offspring","volume":"32","author":"Chen","year":"2022","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6865","article-title":"Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment","volume":"356","author":"Maraka","year":"2017","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606205","article-title":"Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy","volume":"376","author":"Casey","year":"2017","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1004-8189.2021.07.020","article-title":"Effects of iodine nutrition combined with thyroid hormone replacement therapy on subclinical hypothyroidism during pregnancy and pregnancy outcomes","volume":"29","author":"Wang","year":"2021","journal-title":"Chin J Family Plann"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2016.24.41","article-title":"Effect of subclinical hypothyroidism in pregnancy with negative thyroid peroxidase antibody on pregnancy outcome and neonates","volume":"31","author":"Xu","year":"2016","journal-title":"Chin Matern Child Health Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-5293.2020.06.010","article-title":"Effect of intervention on perinatal outcome in pregnancy with subclinical hypothyroidism","volume":"31","author":"Zhang","year":"2020","journal-title":"Chin J Woman Child Health Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1004-8189.2021.07.016","article-title":"Effects of levothyroxine sodium tablets at different times on pregnancy outcome and neurological function of infants with TPOAb-negative subclinical hypothyroidism during pregnancy","volume":"29","author":"Li","year":"2021","journal-title":"Chin J Family Plann"},{"key":"B29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.13404\/j.cnki.cjbhh.2019.06.028","article-title":"Effect of subclinical hypothyroidism intervention during pregnancy on pregnancy outcome","volume":"27","author":"Lu","year":"2019","journal-title":"Chin J Birth Health Heredity"},{"key":"B30","first-page":"121","article-title":"The efficacy evaluation of synthroid in the treatment of pregnant women with subclinical hypothyroidism and its influence on pregnancy outcome","volume":"121","author":"Zheng","year":"2020","journal-title":"Oriental Medicated Diet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.13705\/j.issn.1671-6825.2018.10.071","article-title":"Effect of treatment of tPOAb-negative SCH in early pregnancy on intelligence and motor development of offspring","volume":"54","author":"Guo","year":"2019","journal-title":"J Zhengzhou Univ"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0529-567x.2015.09.003","article-title":"Effect of treatment on perinatal outcome in pregnant women with subclinical hypothyroidism and TPOAb-positive in early pregnancy","volume":"50","author":"Yang","year":"2015","journal-title":"Chin J Obstet Gynecol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1004-583X.2016.03.015","article-title":"Effects of levothyroxine sodium on perinatal outcomes in subclinical hypothyroidism patients with negative thyroid peroxidase antibody in early pregnancy","volume":"31","author":"Zhang","year":"2016","journal-title":"Clin Focus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-0369.2021.17.018","article-title":"Effect of levothyroxine sodium in early treatment of subclinical hypothyroidism during pregnancy","volume":"33","author":"Tu","year":"2021","journal-title":"Med J Chin People's Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3969\/j.issn.1002-3429.2020.04.012","article-title":"Effect of levothyroxine on subclinical hypothyroidism during pregnancy and its influence on pregnancy outcome","volume":"33","author":"He","year":"2020","journal-title":"Clin Misdiag Misther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.14033\/j.cnki.cfmr.2020.10.056","article-title":"Clinical effect of levothyroxine in tPOAB-positive pregnancy with subclinical hypothyroidism","volume":"18","author":"Chen","year":"2020","journal-title":"Chin Foreign Med Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.14009\/j.issn.1672-2124.2019.07.015","article-title":"Effects of levothyroxine on pregnancy hormone levels, thyroid function and pregnancy outcome in patients with subclinical hypothyroidism in pregnancy with negative thyroid peroxidase antibody","volume":"19","author":"Shu","year":"2019","journal-title":"Eval Anal Drug-Use Hospitals China"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2018.21.21","article-title":"Effect of levothyroxine tablets on pregnancy outcome in early pregnancy complicated with subclinical hypothyroidism","volume":"33","author":"Chai","year":"2018","journal-title":"Chin Matern Child Health Care"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz003","article-title":"Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis","volume":"25","author":"Rao","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05245-2","article-title":"Levothyroxine treatment and pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis","volume":"300","author":"Nazarpour","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12902-021-00699-5","article-title":"Levothyroxine and the risk of adverse pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis","volume":"21","author":"Bein","year":"2021","journal-title":"BMC Endocr Disord"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.964084\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T06:11:11Z","timestamp":1660111871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.964084\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":41,"alternative-id":["10.3389\/fendo.2022.964084"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.964084","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"article-number":"964084"}}